Indegene Lifesystems Private Limited announced that it will receive equity round of funding on February 2, 2021. The transaction will include participation from new investors The Carlyle Group Inc. (NasdaqGS:CG) and Brighton Park Capital Management, L.P. for a minority stake. The transaction is subject to customary regulatory approvals. The round will be raised at post-money valuation of $700 million.